PRCSG News

Abstracts  / Posters / Presentations

European Congress of Rheumatology (EULAR) 2020

June 3 – 6, 2020

Virtual meeting

Poster THU0503: PLUTO Trial: Sensitivity Analyses of SRI4 response with Belimumab vs Placebo in Paediatric Patients With Childhood-Onset Systemic Lupus Erythematosus.

OP0291: Tofacitinib for the treatment of polyarticular course juvenile idiopathic arthritis: results of a Phase 3, randomised, double-blind, placebo-controlled withdrawal study.

Poster THU0497: Maintenance Of Minimal Disease Activity Or Inactive Disease Status And Patient-Reported Outcomes In Individual Paediatric Patients With Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept.

Poster SAT0505: Pluto Trial of Intravenous Belimumab in Paediatric Patients with Childhood-Onset Systemic Lupus Erythematosus (cSLE): Patient Responses Over Time.

  ************************************************************************************************************************

October 2019 - Accelerating Drug Development for Polyarticular Juvenile Idiopathic Arthritis (pJIA). View the speaker slides and video recordings.

April 2019 - FDA approves Benlysta (belimumab) for children with lupus who are five years old or above